In vitro evaluation of Eclipta alba against serogroups of Leptospira interrogans

Indian Journal of Pharmaceutical Sciences

Volumn 70, Issue 6, 2008, Pages 788-791

  Prabhu, N ^a   Innocent, Joseph Pushpa ^b   Chinnaswamy, P ^c   Natarajaseenivasan, K ^d   Sarayu, Lakshmi ^b  

^a DR N G P ARTS AND SCIENCE COLLEGE   (India)

^b ANNAMALAI UNIVERSITY   (India)

^c KOVAI MEDICAL CENTER AND HOSPITAL   (India)

^d BHARATHIDASAN UNIVERSITY   (India)

Author keywords

Eclipta alba L.; Leptospira interrogans; Leptospirosis; Micro dilution; Tube dilution

Indexed keywords

ECLIPTA ALBA EXTRACT; ENTOX; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DILUTION; INHIBITION KINETICS; LEPTOSPIRA; LEPTOSPIRA AUSTRALIS; LEPTOSPIRA AUTOMNALIS; LEPTOSPIRA GRIPPOTYPHOSA; LEPTOSPIRA INTERROGANS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SEROTYPE;

EID: 64349083763     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.49124     Document Type: Article

References (14)

1. Elizabeth KM. Antimicrobial activity of Caesalpina digyna on some human pathogenic microorganisms. Indian J Microbiol 2001;46:343-6.
2. Shah NC. Need of cultivation of medicinal herbs used in indigenous systems and traditional medicine. Indian Drugs 1981;18:210-7.
3. Ciceroni L, Stepan E, Pinto A, Pissocaro P, Dettori G, Franzin L, et al. Seroepidemiological trend of human leptospirosis in Italy between 1994 and 1996. Eur J Epidemiol 2000;16:79-86.
4. Jackson LA, Kaufmann AF, Adams WG, Phelps MB, Anderason C, Langkop CW, et al. Outbreak of leptospirosis associated with swimming. Paed Inf Dis J 1993;12:48-54.
5. Barwick RS, Mohammed HO, McDonough PL, White E. Risk factors associated with the likelihood of leptospiral seropositivity in horses in the state of New York. Am J Vet Res 1997;58:1097-103.
6. Burne RJ. Canine leptospirosis and Public Health. Pub Health Rep 1996;70:1229-34.
7. Emmanouilides CE, Kohn OF, Garibaldi R. Leptospirosis complicated by a Jarisch.Herxheimer reaction of adult respiratory distress syndrome: Case report. Clin Inf Dis 1994;18:1004-6.
8. Daher E, Trevisan DM, Marcelo Boryes, Cavalcante, Regina CR, et al. Risk factors for death and changing patterns in leptospirosis acute renal failure. Am J Trop Med Hyg 1998;72:630-4.
9. Chen TZ. Development and present status of leptospiral vaccine and technology. Ann Imm Hung 1986;26:125-31.
10. Hubbert WT. Leptospirosis in California. Pub Health Rep 1997;82:429-34.
11. Mathew LM. Comparative analysis of Acetone, Water and Saponied extracts of Phyllanthus niruri against Leptospira interrogans serogroups in vitro (Dissertation). Periyar University, Salem, Tamilnadu, India; 2001.
12. Ben-yaacov R, Knoller S, Pierard GM. Drug resistance capability of the pathogenic microbes in vitro. Antimicrob Agents Chemother 1994;38:422-6.
13. Palmer MF, Zochowski WJ. Survival of leptospires of commercial blood culture system revisited. J Clin Pathol 2000;53:713-4.
14. Perry CM, Whittingson R, McCnvish D. Diloxanide, oxytetracycline, An update of its antispirochetal activity, Pharmacokinetic properties and therapeutic use in human and bovine leptospirosis. Indian J Med Microbiol 1998;24:221-4.